Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hamsten

Showing results (181-190 of 244) with videos related to

Pageof 25
Sort By:
Thrombosis and Haemostasis|August 1, 1996
Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VIIA Bröijersén, A Hamsten, A Silveira, et al.
European Heart Journal|July 1, 1993
Coronary angiographic changes during 2 years after myocardial infarction largely undetected by repeated tomographic thallium-201 scintigraphy and not reflected by clinical symptomsC G Ericsson, A Hamsten, C Landou, et al.
Lancet (London, England)|July 4, 1987
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarctionA Hamsten, U de Faire, G Walldius, et al.
Human Molecular Genetics|July 13, 1999
A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alphaT Skoog, F M van't Hooft, B Kallin, et al.
Thrombosis and Haemostasis|November 1, 2000
In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive elementW Dichtl, M P Ares, M Stollenwerk, et al.
Diabetologia|November 3, 2001
Fatty acid binding protein expression in different adipose tissue depots from lean and obese individualsR M Fisher, P Eriksson, J Hoffstedt, et al.
Journal of Internal Medicine|September 16, 2004
Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controlsM Bartnik, K Malmberg, A Hamsten, et al.
Diabetologia|September 7, 2005
Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI studyM Wallander, M Bartnik, S Efendic, et al.
Journal of the American College of Cardiology|March 15, 2000
Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatmentG Ruotolo, P Båvenholm, K Brismar, et al.
International Journal of Obesity (2005)|April 25, 2007
Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesityJ Makkonen, J Westerbacka, M Kolak, et al.
Pageof 25

Showing results (181-190 of 244) with videos related to

Sort By:
Pageof 25
Thrombosis and Haemostasis|August 1, 1996
Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VIIA Bröijersén, A Hamsten, A Silveira, et al.
European Heart Journal|July 1, 1993
Coronary angiographic changes during 2 years after myocardial infarction largely undetected by repeated tomographic thallium-201 scintigraphy and not reflected by clinical symptomsC G Ericsson, A Hamsten, C Landou, et al.
Lancet (London, England)|July 4, 1987
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarctionA Hamsten, U de Faire, G Walldius, et al.
Human Molecular Genetics|July 13, 1999
A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alphaT Skoog, F M van't Hooft, B Kallin, et al.
Thrombosis and Haemostasis|November 1, 2000
In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive elementW Dichtl, M P Ares, M Stollenwerk, et al.
Diabetologia|November 3, 2001
Fatty acid binding protein expression in different adipose tissue depots from lean and obese individualsR M Fisher, P Eriksson, J Hoffstedt, et al.
Journal of Internal Medicine|September 16, 2004
Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controlsM Bartnik, K Malmberg, A Hamsten, et al.
Diabetologia|September 7, 2005
Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI studyM Wallander, M Bartnik, S Efendic, et al.
Journal of the American College of Cardiology|March 15, 2000
Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatmentG Ruotolo, P Båvenholm, K Brismar, et al.
International Journal of Obesity (2005)|April 25, 2007
Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesityJ Makkonen, J Westerbacka, M Kolak, et al.
Pageof 25